Search clinical trials for: epirubicin, cyclophosphamide, docetaxel
Total 5809 results
-
Disphar International B.V.CompletedPatients With Advanced or Metastatic Solid Tumors
-
Fundacao ChampalimaudNot yet recruitingTriple Negative Breast Cancer | Early Breast CancerPortugal
-
Amsterdam UMC, location VUmcCristal TherapeuticsCompleted
-
Japan Clinical Oncology GroupMinistry of Health, Labour and Welfare, JapanTerminated
-
Hebei Tumor HospitalUnknown
-
Henan Cancer HospitalRecruitingDiffuse Large B Cell Lymphoma | CD79A Gene Mutation | CD79B Gene MutationChina
-
Societe Internationale d'Oncologie PediatriqueChildren's Cancer and Leukaemia Group; Societe Francaise Oncologie PediatriqueCompletedSarcoma | Small Intestine Cancer | Ovarian CancerFrance, United Kingdom, Ireland
-
The Netherlands Cancer InstituteActive, not recruitingBreast CancerNetherlands
-
NSABP Foundation IncGenentech, Inc.; US Oncology ResearchCompleted
-
National Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)WithdrawnBreast CancerUnited States
-
Zhejiang Cancer HospitalNot yet recruitingHepatocellular CarcinomaChina
-
Cancer Institute and Hospital, Chinese Academy...Recruiting
-
Jinling Hospital, ChinaActive, not recruitingStomach Neoplasms | Gastric CancerChina
-
Chong Kun Dang PharmaceuticalCompletedAdvanced Solid CancersKorea, Republic of
-
Mast Therapeutics, Inc.CompletedAdvanced CancerUnited States, Argentina, Estonia
-
Royal Marsden NHS Foundation TrustCompletedAdenocarcinoma of OesophagusUnited Kingdom
-
Gyeongsang National University HospitalCompletedNon-small Cell Lung CancerKorea, Republic of
-
NSABP Foundation IncHoffmann-La Roche; Genentech, Inc.; Cancer International Research Group (CIRG)TerminatedBreast CancerKorea, Republic of, United States, Canada, Spain, Ireland, Australia, Argentina, China, United Kingdom, Germany, Brazil, Hong Kong, France, Israel, Taiwan, Serbia, Belgium, Thailand, Croatia, Egypt, Italy, Philippines, Bosnia and Herzegovina and more
-
Hellenic Oncology Research GroupUniversity Hospital of CreteCompleted
-
Astellas Pharma Global Development, Inc.CompletedCLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction | CLDN18.2-positive Adenocarcinoma of Esophagus | CLDN18.2-positive Gastric AdenocarcinomaBulgaria, Czechia, Germany, Latvia, Russian Federation, Ukraine
-
Fox Chase Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | LeukemiaUnited States
-
BayerCompleted
-
FENG Ji-fengChinese Anti-Cancer AssociationUnknownDiffuse Large B-cell LymphomaChina
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Not yet recruiting
-
INSYS Therapeutics IncWithdrawnProstate CancerUnited States
-
Samyang Biopharmaceuticals CorporationTerminatedBreast CancerKorea, Republic of
-
Hoffmann-La RocheGenentech, Inc.; Breast International GroupActive, not recruitingBreast CancerUnited States, Belgium, Canada, Australia, Austria, Bulgaria, China, Croatia, Denmark, France, Germany, Guatemala, Hungary, Ireland, Italy, Korea, Republic of, Panama, Slovenia, Spain, Taiwan, United Kingdom, Colombia, Czechia, El Salvador and more
-
Sun Yat-sen UniversityFirst Affiliated Hospital, Sun Yat-Sen University; Sun Yat-Sen Memorial Hospital...Active, not recruitingBreast Cancer | Neoadjuvant ChemotherapyChina
-
West German Study GroupAGO GermanyCompletedBreast CancerGermany
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)CompletedHead and Neck Cancer | Gastric Cancer | Esophageal Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Liver Cancer | Extrahepatic Bile Duct CancerUnited States
-
University of BernSpitalzentrum BielNot yet recruitingBladder Cancer | Non-muscle Invasive Bladder Cancer | Low-riskSwitzerland
-
Infinity Pharmaceuticals, Inc.CompletedNon Small Cell Lung CancerUnited States, Hungary, Taiwan, Korea, Republic of, Russian Federation, Romania
-
University of Turin, ItalyUnknownAdvanced Prostate CancerItaly
-
University of LeedsCompleted
-
Air Force Military Medical University, ChinaUnknown
-
AIDS Malignancy ConsortiumNational Cancer Institute (NCI); Memorial Sloan Kettering Cancer CenterNot yet recruitingHIV Infection | Recurrent Diffuse Large B-Cell Lymphoma | Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | Recurrent... and other conditionsUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedClinical Stage IV Gastric Cancer AJCC v8 | Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 | Metastatic Gastric Adenocarcinoma | Metastatic Gastroesophageal Junction Adenocarcinoma | Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 | Postneoadjuvant... and other conditionsUnited States
-
University of ChicagoTerminatedNon-small Cell Lung CancerUnited States
-
Hellenic Oncology Research GroupUniversity Hospital of CreteCompleted
-
Anhui Medical UniversityUnknownStage IV Gastric Cancer With MetastasisChina
-
Memorial Sloan Kettering Cancer CenterGenentech, Inc.; Weill Medical College of Cornell UniversityCompletedGastric Cancer | Esophageal CancerUnited States
-
Hebei Medical University Fourth HospitalCompleted
-
Ascenta TherapeuticsCompletedNon-small Cell Lung CancerRussian Federation, United States, Ukraine
-
Haruhiko FukudaMinistry of Health, Labour and Welfare, JapanCompleted
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedBreast CancerUnited States, Poland, Ukraine, United Kingdom, Spain, Israel, Bulgaria, Romania, Serbia, South Africa, Russian Federation, Hungary, Lithuania, Netherlands, Latvia, Portugal, Estonia, France
-
Zhenzhen LiuRecruitingBreast Cancer | Triple Negative Breast Cancer | CamrelizumabChina
-
Western Regional Medical CenterTerminated